Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Sponsored by Merck Sharp & Dohme LLC
About this study
Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA. This study assesses the efficacy, safety, and tolerability of tulisokibart in adult participants with active PsA. In this study, researchers will look at different doses of tulisokibart. Researchers want to learn if at least one of the study doses of tulisokibart works better than a placebo to lessen PsA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.
This study consists of a 16-week Placebo-controlled Period and a 112-week Long-term Extension (LTE), which is composed of a 40-week Main Extension and a 72-week Optional Extension.
Where this study is enrolling (18)
- Call (480) 443-8400
Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120)
Tucson, Arizona
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 480-443-8400
Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117)
Sun City, Arizona
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 951-924-6500
Medvin Clinical Research - Riverside ( Site 5115)
Riverside, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 877-972-7576
Cohen Medical Centers ( Site 5111)
Thousand Oaks, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 213-281-5146
Medvin Clinical Research - Tujunga ( Site 5113)
Tujunga, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 18 locations
- Call 305-652-6676
Arthritis and Rheumatic Disease Specialties ( Site 5105)
Aventura, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 813-392-1103
International Center for Research ( Site 5124)
Tampa, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 208-706-9088
St. Luke's Clinic - Rheumatology - Boise ( Site 5109)
Boise, Idaho
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 240-283-2046
Arthritis and Rheumatism Associates - Rockville ( Site 5127)
Rockville, Maryland
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 410-550-0579
Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center ( Site 5132)
Baltimore, Maryland
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 816-531-0930
Kansas City Physician Partners ( Site 5119)
Kansas City, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 402-420-1212
Physician Research Collaboration, LLC ( Site 5102)
Lincoln, Nebraska
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 929-455-2500
Joseph S. and Diane H. Steinberg Ambulatory Care Center ( Site 5106)
Brooklyn, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 704-248-8577
Joint and Muscle Research Institute ( Site 5108)
Charlotte, North Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 814-693-0300
Altoona Center for Clinical Research ( Site 5110)
Duncansville, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 215-662-2454
Hospital of the University of Pennsylvania ( Site 5134)
Philadelphia, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 843-572-4840
Articularis Healthcare Group dba: Low Country Rheumatology ( Site 5128)
Summerville, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 832-237-0400
Greater Houston Rheumatology ( Site 5103)
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓The main inclusion criteria include but are not limited to the following:
- ✓Has a clinical diagnosis of PsA and fulfillment of the Classification Criteria for Psoriatic Arthritis (CASPAR) criteria at Screening, with symptom onset ≥6 months before Screening.
- ✓Has a diagnosis of active plaque psoriasis or documented history of plaque psoriasis.
- ✓Has history of biologic disease-modifying antirheumatic drug (bDMARD)-naïve or bDMARD-inadequate response/intolerant.
Exclusion criteria
- ✕The main exclusion criteria include but are not limited to the following:
- ✕Has any arthritis with onset before age 17 years or current diagnosis of inflammatory joint disease other than PsA (such as, but not limited to, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, myositis, etc), or any other conditions that may, in the judgment of the investigator, interfere with the assessment of PsA.
- ✕Has a skin condition diagnosis, other than psoriasis that may, in the judgment of the investigator, interfere with the assessment of psoriasis.
- ✕Has a history of cancer (except fully treated nonmelanoma skin cancers or cervical carcinoma in situ after complete surgical removal) and is disease free for \<5 years before Randomization.
- ✕Has any active infection.
- ✕Has known allergies, hypersensitivity, or intolerance to tulisokibart of its excipients.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.